Alcohol Use Disorder Medications After Residential Treatment: The Three FDA-Approved Options, Timing Rules, and What to Ask Before Discharge

Most people who complete residential treatment for alcohol use disorder leave with a discharge plan that covers therapy, housing, and support meetings. Fewer leave with a clear plan for medication, even though medications approved specifically for alcohol use disorder exist, are not addictive, and can be started or continued after residential care. This guide explains the three options, the timing rules that decide which one fits, and the questions to settle with the treatment team before the discharge date.

The Three FDA-Approved Medications, in One Paragraph

Three medications are approved by the FDA for alcohol use disorder in the United States: naltrexone, acamprosate, and disulfiram. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), all three are nonaddictive, and they can be used alone or alongside counseling. Naltrexone comes as a daily pill or as an extended-release injection given every four weeks, and it reduces the urge to drink. Acamprosate is a pill that eases the discomfort some people feel during early abstinence and is usually started a few days after drinking stops. Disulfiram is a daily pill that causes an unpleasant physical reaction if alcohol is consumed. None of the three treats alcohol withdrawal itself, so for a person leaving residential treatment the practical questions are which medication fits their health history, and whether the prescription and the first follow-up appointment are confirmed before discharge.

Withdrawal Comes First, and It Needs Medical Supervision

These medications are for staying stopped, not for stopping. Alcohol withdrawal can cause seizures and delirium tremens, and it requires medical supervision. Anyone who has been drinking daily should not stop abruptly at home and then plan to begin a medication the following week. Withdrawal should be managed in a medically supervised setting, and medication for long-term recovery is typically discussed once that stage is complete. The same seizure risk applies to anyone who is also dependent on benzodiazepines, and those medications should never be stopped suddenly without a prescriber involved.

If you are unsure whether detox needs to come before residential treatment, our admissions team can walk through it with you at (877) 328-1968.

Naltrexone: Timing Rules That Matter

Naltrexone is the medication most people have heard of, and it is often a reasonable first conversation. Two timing rules decide whether it is safe to start.

Opioids in the last two weeks: naltrexone blocks opioid receptors, so starting it while opioids are still in the body can bring on sudden withdrawal. SAMHSA’s guidance on naltrexone describes waiting at least 7 days after the last use of short-acting opioids and 10 to 14 days after long-acting opioids. That includes prescribed pain medication and opioid-containing cough or diarrhea medicine, not just illicit drugs.

Physical dependence on alcohol: SAMHSA notes that a person starting naltrexone for alcohol use disorder must not be physically dependent on alcohol, which is why it is usually started after detox.

One safety point deserves to be stated plainly. A person who has stopped using opioids while on naltrexone has lower tolerance. If they stop the medication and return to opioid use, a dose they once handled can be life-threatening. Anyone with a history of opioid use should leave treatment with naloxone and know how to use it.

The injectable form is given every four weeks by a clinician. For some people that removes the daily decision to take a pill, but it also means the next injection appointment has to be booked before discharge, not after.

Acamprosate: Often the Option When Others Are Ruled Out

SAMHSA describes acamprosate as well tolerated, with no potential for misuse and no clinically significant drug interactions. It can be used alongside psychiatric medications and can be continued if a person returns to drinking. It is also often considered for people who cannot take naltrexone because of liver disease or because they are being treated with opioids, including buprenorphine or methadone.

The main exclusion is the kidneys. Acamprosate should not be started in severe kidney disease, so recent kidney function labs are part of the decision. If those labs were drawn during residential care, ask for a copy to go with your discharge paperwork.

Disulfiram: Effective Only With a Clear Agreement

Disulfiram works differently. It does not reduce cravings. According to SAMHSA, it causes flushing, nausea, vomiting, palpitations, and other symptoms when alcohol enters the body, beginning about 10 minutes after drinking. It should not be taken for 12 to 48 hours after drinking, and a reaction can still occur for up to two weeks after the last dose. Alcohol hidden in mouthwash, cough syrup, sauces, vinegars, and some baked goods can trigger it.

Because of this, disulfiram suits people whose goal is complete abstinence and who want a firm external commitment. SAMHSA notes it may work better when a family member or provider observes the daily dose. That arrangement has to be agreed to openly. Disulfiram must never be given to someone without their knowledge. It is also not appropriate for people with severe heart disease, severe liver disease, or a history of psychosis.

Why Medication Plans Fall Apart After Discharge

From the discharge-planning side of residential care, the problem is rarely that the wrong medication was chosen. It is usually logistics. These are the gaps that come up most often:

• The prescription runs out before the first appointment: a person leaves with a short supply, and the first outpatient prescriber visit is weeks away.
• No named prescriber: the discharge summary says “continue naltrexone” but does not say who will write the next prescription.
• The injection is not scheduled: the four-week injectable needs a booked appointment and, often, insurance approval in advance.
• The pharmacy does not stock it: acamprosate and the injectable form are not always on the shelf, so the first fill can be delayed.
• Family is not briefed: with disulfiram in particular, the people at home need to know about hidden alcohol and what a reaction looks like.

None of these require a clinical decision. Each is a phone call that is far easier to make while the person is still in residential care, with staff and records in the same building.

Five Questions to Ask Before the Discharge Date

Bring this list to your next treatment team meeting or discharge planning session, and write the answers down:

1. Which of the three medications was considered for me, and why was it chosen or ruled out?
2. Who is my prescriber after discharge, and what is the date of the first appointment?
3. How many days of medication am I leaving with, and does that cover the time until that appointment?
4. Has my pharmacy confirmed it has the medication, and has my insurance approved it?
5. Which labs (liver or kidney function) were done here, and will a copy go to my next provider?

If the answer to any of these is “we’ll figure that out later,” that is the item to resolve first. If you are stepping down to an outpatient program, confirm whether that program has its own prescriber or whether you need a separate one.

Insurance and Cost

Coverage for these medications varies by plan, and the injectable form in particular may require prior authorization. Ask the treatment team to start that request before discharge rather than after. If you are still deciding on care, you can verify your insurance with us, or call (877) 328-1968 to talk through what your plan is likely to cover.

Medication Is One Part of the Plan

NIAAA and SAMHSA both describe these medications as one component of treatment, used together with counseling and ongoing support. They do not cure alcohol use disorder, and they work best when someone is checking in regularly. A return to drinking while on naltrexone or acamprosate is a reason to call the prescriber, not a reason to stop the plan. If you are a family member, the most useful thing you can do is make sure the five questions above have written answers before your loved one comes home.

If you or someone you love needs help with alcohol use in Northern California, call Bodhi Addiction Treatment at (877) 328-1968. If someone is in immediate danger, call 911. For a mental health or suicidal crisis, call or text 988.

This article is for educational purposes only and is not medical advice. Do not start, stop, or change any medication without talking to a licensed prescriber. Alcohol and benzodiazepine withdrawal can be life-threatening and require medical supervision.